HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

Repligen Corporation (RGEN) Stock Price, Analysis & Trade Signals

$148.06+0.93 (+0.63%)

Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses Protein A ligands, which serve as the key binding elements within Protein A affinity chromatography resins, as well as specialized cell culture growth factors. In the realm of chromato…

Market Cap
$6.41B
CEO
Olivier Loeillot
Employees
2,000
IPO Date
1986-04-29
Website
www.repligen.com

Tabs · Summary · AI Insight · Feed · News · Financials · Transcript · SEC Filings · Insider · Politics